(S (NP (DT This) (NN paper)) (VP (VBZ explores) (SBAR (IN whether) (S (NP (NP (DT the) (NN use)) (PP (IN of) (NP (NP (NN drug) (NNS reviews)) (CC and) (NP (JJ social) (NNS media))))) (VP (MD could) (VP (VB be) (VP (VBN leveraged) (PP (IN as) (NP (NP (JJ potential) (JJ alternative) (NNS sources)) (PP (IN for) (NP (NP (NN pharmacovigilance)) (PP (IN of) (NP (NP (JJ adverse) (NN drug) (NNS reactions)) (PRN (-LRB- -LRB-) (NP (NNP ADRs)) (-RRB- -RRB-)))))))))))))) (. .))
(S (NP (PRP We)) (VP (VBD examined) (NP (NP (DT the) (NN performance)) (PP (IN of) (NP (NNP BERT)))) (PP (RB alongside) (NP (NP (CD two) (NNS variants)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (VP (VBN trained) (PP (IN on) (NP (NP (JJ biomedical) (NNS papers)) (, ,) (NP (NNP BioBERT7)) (, ,) (CC and) (NP (NP (JJ clinical) (NNS notes)) (, ,) (NP (NNP Clinical) (NNP BERT8)))))))))))) (. .))
(S (NP (NP (DT A) (NN variety)) (PP (IN of) (NP (CD 8) (JJ different) (NNP BERT) (NNS models)))) (VP (VBD were) (VP (JJ fine-tuned) (CC and) (VBN compared) (PP (IN across) (NP (CD three) (JJ different) (NNS tasks))) (SBAR (IN in) (NN order) (S (VP (TO to) (VP (VB evaluate) (NP (NP (PRP$ their) (JJ relative) (NN performance)) (PP (TO to) (NP (CD one) (DT another))) (PP (IN in) (NP (DT the) (NNP ADR) (NNS tasks)))))))))) (. .))
(S (NP (DT The) (NNS tasks)) (VP (VBP include) (NP (NP (NP (JJ sentiment) (NN classification)) (PP (IN of) (NP (NN drug) (NNS reviews)))) (, ,) (NP (NP (NN presence)) (PP (IN of) (NP (NNP ADR))) (PP (IN in) (NP (NN twitter) (NNS postings)))) (, ,) (CC and) (NP (NP (VBN named) (NN entity) (NN recognition)) (PP (IN of) (NP (NNP ADRs))) (PP (IN in) (NP (NN twitter) (NNS postings)))))) (. .))
(S (NP (NNP BERT)) (VP (VBZ demonstrates) (NP (PRP$ its) (NN flexibility)) (PP (IN with) (NP (NP (JJ high) (NN performance)) (PP (IN across) (NP (DT all) (CD three) (JJ different) (NN pharmacovigilance) (VBN related) (NNS tasks)))))) (. .))
